SE406196B - Nytt forfarande for framstellning av terapeutiskt verdefulla antiinflammatoriskt verkande 1-alkyl-4-fenyl-resp-4-(2'-tienyl)-2(1h)-kinazolinoner - Google Patents

Nytt forfarande for framstellning av terapeutiskt verdefulla antiinflammatoriskt verkande 1-alkyl-4-fenyl-resp-4-(2'-tienyl)-2(1h)-kinazolinoner

Info

Publication number
SE406196B
SE406196B SE7208555A SE855572A SE406196B SE 406196 B SE406196 B SE 406196B SE 7208555 A SE7208555 A SE 7208555A SE 855572 A SE855572 A SE 855572A SE 406196 B SE406196 B SE 406196B
Authority
SE
Sweden
Prior art keywords
chinazolinones
resp
thienyl
phenyl
alkyl
Prior art date
Application number
SE7208555A
Other languages
English (en)
Swedish (sv)
Inventor
W G Salmond
G E Hardtmann
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE406196B publication Critical patent/SE406196B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/80—Oxygen atoms
    • C07D239/82—Oxygen atoms with an aryl radical attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/22—Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE7208555A 1971-07-08 1972-06-29 Nytt forfarande for framstellning av terapeutiskt verdefulla antiinflammatoriskt verkande 1-alkyl-4-fenyl-resp-4-(2'-tienyl)-2(1h)-kinazolinoner SE406196B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16096071A 1971-07-08 1971-07-08

Publications (1)

Publication Number Publication Date
SE406196B true SE406196B (sv) 1979-01-29

Family

ID=22579209

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7208555A SE406196B (sv) 1971-07-08 1972-06-29 Nytt forfarande for framstellning av terapeutiskt verdefulla antiinflammatoriskt verkande 1-alkyl-4-fenyl-resp-4-(2'-tienyl)-2(1h)-kinazolinoner

Country Status (26)

Country Link
US (1) US4066665A (xx)
JP (4) JPS577150B1 (xx)
AT (1) AT338270B (xx)
BE (1) BE785937A (xx)
BG (1) BG19170A3 (xx)
CA (1) CA1002953A (xx)
CH (2) CH602668A5 (xx)
CS (1) CS189583B2 (xx)
DD (3) DD101400A5 (xx)
DE (3) DE2254326A1 (xx)
ES (1) ES404598A1 (xx)
FI (1) FI57401C (xx)
FR (2) FR2144753B1 (xx)
GB (1) GB1383255A (xx)
IE (1) IE36541B1 (xx)
IL (1) IL39845A (xx)
NL (1) NL7209322A (xx)
NO (1) NO136838C (xx)
OA (1) OA04129A (xx)
PH (1) PH13454A (xx)
PL (1) PL89011B1 (xx)
RO (1) RO63336A (xx)
SE (1) SE406196B (xx)
SU (1) SU528032A3 (xx)
YU (1) YU177672A (xx)
ZA (1) ZA724688B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3996227A (en) * 1971-07-08 1976-12-07 Sandoz, Inc. 7-Methyl-1-isopropyl-4-phenyl-5,6,7,8-tetrahydro-2(1H)-quinazolinone
JPS5271483A (en) * 1975-12-11 1977-06-14 Sumitomo Chem Co Ltd Synthesis of 2(1h)-quinazolinone derivatives
CH642638A5 (de) * 1977-09-06 1984-04-30 Sandoz Ag Verfahren zur herstellung von chinazolin-2(1h)-onen.
JPS5661198A (en) * 1979-10-24 1981-05-26 Shinto Paint Co Ltd Method of painting board for wiring conductive print
JPS5878495A (ja) * 1981-11-05 1983-05-12 セイコーエプソン株式会社 プリント配線板の製造方法
JPS5878494A (ja) * 1981-11-05 1983-05-12 セイコーエプソン株式会社 プリント配線板の製造方法
JPS58222593A (ja) * 1982-02-24 1983-12-24 日立化成工業株式会社 金属芯入りプリント配線板用基板の製造法
US4601916A (en) * 1984-07-18 1986-07-22 Kollmorgen Technologies Corporation Process for bonding metals to electrophoretically deposited resin coatings
JPS6133463U (ja) * 1984-07-30 1986-02-28 三菱電線工業株式会社 金属ベ−ス基板
JPS61156000U (xx) * 1985-03-19 1986-09-27
US6951707B2 (en) * 2001-03-08 2005-10-04 Ppg Industries Ohio, Inc. Process for creating vias for circuit assemblies

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3553199A (en) * 1967-03-17 1971-01-05 Hoffmann La Roche Reaction of 2-aminobenzophenone amines and benzhydryl amines with di-leaveing group-substituted ethane
US3723432A (en) * 1968-11-12 1973-03-27 Sandoz Ag 1-substituted-4-aryl-2(1h)-quinazolinones and their preparation
US3549635A (en) * 1968-07-01 1970-12-22 Sandoz Ag Preparation of substituted-2(1h)-quinazolinones
US3563990A (en) * 1969-03-18 1971-02-16 Sandoz Ag 1-substituted-4-aryl-2(1h)-quinazolinones
DD202218A5 (de) * 1982-04-27 1983-08-31 Orion Radio Verfahren und schaltungsanordnung zur erzeugung einer phasengetasteten kohaerenten traegerfrequenz

Also Published As

Publication number Publication date
IL39845A (en) 1975-11-25
BE785937A (fr) 1973-01-08
FR2144753A1 (xx) 1973-02-16
IE36541B1 (en) 1976-11-24
FR2208681B1 (xx) 1978-01-06
GB1383255A (en) 1974-02-12
DE2232919A1 (de) 1973-02-08
JPS5639075A (en) 1981-04-14
NO136838C (no) 1977-11-16
ZA724688B (en) 1974-02-27
DD106175A5 (xx) 1974-06-05
AU4437172A (en) 1974-01-10
OA04129A (fr) 1979-11-30
CS189583B2 (en) 1979-04-30
JPS56115758A (en) 1981-09-11
JPS585198B2 (ja) 1983-01-29
IE36541L (en) 1973-01-08
AT338270B (de) 1977-08-10
PH13454A (en) 1980-04-23
CA1002953A (en) 1977-01-04
ES404598A1 (es) 1975-11-16
US4066665A (en) 1978-01-03
JPS5639076A (en) 1981-04-14
BG19170A3 (bg) 1975-04-30
DE2254326A1 (de) 1974-08-08
CH602668A5 (xx) 1978-07-31
ATA582972A (de) 1976-12-15
FR2208681A1 (xx) 1974-06-28
DD106171A5 (xx) 1974-06-05
FR2144753B1 (xx) 1976-09-17
JPS577150B1 (xx) 1982-02-09
SU528032A3 (ru) 1976-09-05
NL7209322A (xx) 1973-01-10
DE2254325A1 (de) 1973-07-12
YU177672A (en) 1982-02-28
FI57401B (fi) 1980-04-30
NO136838B (no) 1977-08-08
CH587804A5 (xx) 1977-05-13
IL39845A0 (en) 1972-09-28
FI57401C (fi) 1980-08-11
RO63336A (fr) 1978-07-15
JPS58422B2 (ja) 1983-01-06
DD101400A5 (xx) 1973-11-05
PL89011B1 (xx) 1976-10-30

Similar Documents

Publication Publication Date Title
SE430329B (sv) Forfarande for framstellning av nya terapeutiskt verksamma foreningar
NO147025C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme pyridinyl-2(1h)-pyridinoner
NO136837C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive pleuromutiliner
SE403286B (sv) Mellanprodukter for framstellning av 1,4-hydroximorfinanderivat
SE406196B (sv) Nytt forfarande for framstellning av terapeutiskt verdefulla antiinflammatoriskt verkande 1-alkyl-4-fenyl-resp-4-(2'-tienyl)-2(1h)-kinazolinoner
SE418402B (sv) Vidareutveckling av forfaranden enligt patentet 404 530 for framstellning av d-homosteroider av pregnanserien
NO142303C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme oksazolderivater
NO144153C (no) Fremgangsmaate for fremstilling av delta3-7-acylamido-3-metyl-cefem-4-karboksylsyrer
NO141755C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme dotriacontapeptidamider
NO142260C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive tienotriazolodiazepinderivater
SE400764B (sv) Forfarande for framstellning av substituerade 3-hydroximetylisokinoliner
BE780630A (fr) Nouveaux derives d'imidazo-pyridine
NO138285C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive lincomycinderivater
NO138767C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive nitrosoureaderivater
BE784969A (fr) Nouveaux derives d'imibenzolidinones et procede pour leur preparation
FI56371B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara bensoylestrar av 1,8,9-trihydroxiantracen
NO136841C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive fenylimidazolidinoner
NO141895C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme nitroimidazolderivater
SE415838B (sv) Nya mellanprodukter for framstellning av 3-substituerade 7-alfa-aminoarylacetamido-cefalosporiner
NO142909C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-benzazoninderivater
SE408553B (sv) Analogiforfarande for framstellning av 1-substituerade -4-fenyl-2(ih)-kinazolinoner
SE385480B (sv) Forfarande for framstellning av 2 (1h)-kinazolinon-derivat
BE777967A (fr) Preparation d'ortho-chlorophenols
NO140733C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk virksomme halogenpyrazolderivater
SE385873B (sv) Forfarande for framstellning av 3-aryloxi-1-alkylamino-2-propanol